Medical Editor: John P. Cunha, DO, FACOEP
Bactroban Ointment (mupirocin ointment) is a topical (for the skin) antibiotic used to treat infections of the skin such as impetigo. Bactroban Ointment is available in generic form. Common side effects of Bactroban Ointment include:
- redness, or
- pain at first as your body adjusts to it.
- dry skin
- increased pus, and
- allergic reactions (including anaphylaxis, hives, skin swelling, and generalized rash)
- persistent diarrhea,
- abdominal or stomach pain/cramping, or
- blood or mucus in your stool.
A small amount of Bactroban Ointment should be applied to the affected area three times daily. The area treated may be covered with gauze dressing. Other topical medications may change the way your skin absorbs Bactroban Ointment. Avoid using other products on the same area at the same time unless directed to do so by your doctor. Tell your doctor all medications you use. Bactroban Ointment should be used only when prescribed during pregnancy. It is not known if this drug passes into breast milk. Consult your doctor before breastfeeding.
Our Bactroban Ointment (mupirocin ointment) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Serious side effects are not expected to occur with mupirocin topical therapy. Stop using mupirocin topical and see your doctor if you experience unusual blistering, itching, redness, peeling, dryness, or irritation of the skin.
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Bactroban Ointment (Mupirocin)
The following adverse reactions are discussed in more detail in other sections of the labeling:
- Severe Allergic Reactions [see WARNINGS AND PRECAUTIONS]
- Eye Irritation [see WARNINGS AND PRECAUTIONS]
- Local Irritation [see WARNINGS AND PRECAUTIONS]
- Clostridium difficile-Associated Diarrhea [see WARNINGS AND PRECAUTIONS]
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice.
The following local adverse reactions were reported by at least 1% of subjects in connection with the use of BACTROBAN ointment in clinical trials: burning, stinging, or pain in 1.5% of subjects; itching in 1% of subjects. Rash, nausea, erythema, dry skin, tenderness, swelling, contact dermatitis, and increased exudate were reported in less than 1% of subjects.
In addition to adverse reactions reported from clinical trials, the following reactions have been identified during postmarketing use of BACTROBAN ointment. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. These reactions have been chosen for inclusion due to a combination of their seriousness, frequency of reporting, or potential causal relationship to BACTROBAN ointment.
Immune System Disorders
Read the entire FDA prescribing information for Bactroban Ointment (Mupirocin)
© Bactroban Ointment Patient Information is supplied by Cerner Multum, Inc. and Bactroban Ointment Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.